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Vascular Procedure Outcome Payer Status
Adjusted* Odds
Ratio (95% CI) P Value
Bypass Surgery Death Medicare 1.40 (1.25-1.58) <0.001
Medicaid 0.82 (0.66-1.03) 0.94
Self-Pay 0.96 (0.68-1.35) 0.80
Endovascular
Treatment
Death Medicare 1.40 (1.26-1.55) <0.001
Medicaid 1.35 (1.13-1.62) 0.001
Self-Pay 1.31 (0.97-1.78) 0.08
Amputation Death Medicare 1.56 (1.39-1.74) <0.001
Medicaid 1.41 (1.20-1.66) <0.001
Self-Pay 1.11 (0.80-1.53) 0.54
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comResults: 100% of CTO’s in this series were crossed successfully via the true lumen
without the use of assist or re-entry devices. Mean CTO crossing ﬂuoroscopy time was
0.24 (14.4 seconds)  0.36 minutes using the Ocelot. Mean lesion length treated was
18.6 cm (18.63  8.58 cm) (Table 1). The treated lesions represented a spectrum of
calciﬁcation (mild/none¼2; moderate¼8; severe¼6).
Conclusions: The Ocelot catheter successfully crosses peripheral arterial chronic total
occlusions while eliminating, or signiﬁcantly reducing ﬂuoroscopic exposure and
associated contrast administration.
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Background: Chronic total occlusions (CTO) of the superﬁcial femoral artery (SFA)
are a challenging subset of lesions encountered in peripheral interventions. CTO’s of
the SFA are commonly crossed either with an intraluminal (IL) or re-entry device
assisted subintimal (SI) approach followed by stenting. Even though both these
techniques have a high immediate procedural success rate the long term outcomes of
each approach are not well studied.
Methods: We studied 215 patients (pts) (254 limbs) with obstructive SFA disease
treated with nitinol self-expanding stents of comparable lesion length; there were 205
(81%) limbs with CTO and 49 (19%) pts with non-CTO. We analyzed in-stent
restenosis (ISR) rates as well as demographic, procedural and laboratory character-
istics in 3 subgroups of pts: without CTO; with CTO crossed IL; and with CTO
crossed SI.Non-CTO
N¼49
CTO IL
N¼155
CTO SI
N¼50
Age (years) 73.029.1 71.94 9.5 74.9 7.9
Mean stented length, mm 248.872.5 251.8199.2 280.091.9
GFR ml/min 52.322.3 62.6  20.5 58.621.9
Rutherford class 3 34(70%) 119(79%) 35(70%)
Rutheford class ‡4 15(30%) 32(21%) 15(30%)
Mean run-off score 5.12.5 3.92.8 3.92.9
Mean follow up period, mo 18.414.7 20.516.5 17.216.9
Mean duration to ISR, mo 13.311.8 13.09.2 13.310.4
ISR rate (%) 23(47%) 66(42%) 24(48%)Results: Baseline and procedural characteristcis of the studied groups presented in the
table. There were no signiﬁcant differences in the mean time to ISR, stented lesion
length, as well as other demographic, laboratory, and procedural parameters between
the studied groups except mean run-off score that was higher in non-CTO group (non
CTO vs. SI CTO, p¼0.05; non-CTO vs. IL CTO, p¼0.01). During follow up period of
19.2616.14 months, ISR was diagnosed in: 23 (47%) of pts of non-CTO group; 66
(42%) of IL CTO; and 24 (48%)pts of SI CTO group respectively. There were no
signiﬁcant differences in ISR rates between the groups (non-CTO vs. IL CTO,
p¼0.59; non-CTO vs. SI CTO, p¼0.9; IL CTO vs. SI CTO, p¼0.5).B158 JACC Vol 64/1Conclusions: In patients with long SFA lesions, we observed similar SFA ISR rates
between patients with and without CTO. Furthermore, in CTO group the long term
vessel patency was not affected by whether CTO was crossed using intraluminal or
subintimal approach.
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Background: Peripheral arterial disease (PAD) affects >8 million in US. Previous
studies suggested that patients with Medicare, Medicaid or no insurance received
poorer quality of care leading to worse outcomes in comparison to patients with
private insurance.
Methods: We analyzed all hospitalized PAD patients records from 01/2007 through
12/2011 in Nationwide Inpatient Sample (NIS) database. Temporal trends of pre-
senting diagnoses as well as vascular procedures performed (endovascular treatment,
bypass surgery and amputation) were analyzed. In addition, the unadjusted and
adjusted rates of adverse in-hospital outcomes (death, myocardial infarction, bleeding,
vascular complications, and acute renal failure (ARF)) were examined.
Results: The frequency of endovascular treatment for claudication from 2007 to 2011
decreased by 39.4%, while the annual incidence of bypass surgery and amputation
remained unchanged. Medicare (n¼731,264) and Medicaid (n¼72,050) patients were
more likely to undergo amputation than private insurance/HMO population
(n¼22,896), (adjusted OR 1.13, 95%CI 1.10-1.16, p< 0.001 and OR 1.24, 95%CI
1.20-1.29, p< 0.001, respectively). Both Medicare and Medicaid patients were less
likely to undergo bypass surgery (adjusted OR 0.82, 95%CI 0.81-0.84, p< 0.001 for
Medicare and OR 0.87, 95%CI 0.85-0.90, p< 0.001 for Medicaid), but more likely to
undergo endovascular procedures (adjusted OR 1.18, 95%CI 1.17-1.20, p< 0.001 for
Medicare and OR 1.03, 95%CI 1.01-1.06, p¼0.02 for Medicaid). Medicare and
Medicaid status was associated with worse in-hospital outcomes (Table).Conclusions: Medicare and Medicaid patients were more likely to undergo amputa-
tion and less likely to undergo vascular bypass surgery. Medicare or Medicaid status
was associated with worse in-hospital outcomes compared to private insurance/HMO
status.
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Background: Recent studies have reported presence of poor run-off vessels was
related to lower patency rates of SFA lesions, however it is still uncertain the role of
below-the-knee intervention (BTKI) for patency of SFA. The aim of this study was to
evaluate the impact of BTKI on the patency of SFA lesions after concomitant
treatment.
Methods: Percutaneous angioplasty with primary stenting at SFA was performed in
110 limbs (65 with BTKI) with 0 or 1 patent run-off vessel. Loss of patency was
deﬁned that aggravated ischemic symptoms with deterioration of calf-brachial index
by 0.15 from the maximum postprocedural level or stenosis by duplex ultrasound,1/Suppl B j September 13–17, 2014 j TCT Abstracts/Iliac and SFA
